logo conference-reports

Hasil Konferensi

Educational funding by logo MSD Oncology

ELCC 2019 - “End of story” for maintenance immunotherapy in unselected patients with extensive small cell lung cancer?

Presentation of new data from the CheckMate 451 trial adds to disappointment in SCLC